Brief communication: Glomerulonephritis in patients with hepatitis C cirrhosis undergoing liver transplantation

Brendan M McGuire1, Bruce A Julian, J Steve Bynon

  • 1University of Alabama at Birmingham, Birmingham, Alabama 35294-0005, USA. bmcguire@uab.edu

Insights

Hepatitis C virus (HCV) patients often develop kidney problems after liver transplants. Immune-complex glomerulonephritis is common in HCV cirrhosis and can be silent, potentially leading to renal failure post-transplant.

Area of Science:

  • Nephrology
  • Hepatology
  • Transplantation Medicine

Background:

  • Hepatitis C virus (HCV) infection is a common cause of end-stage liver disease.
  • HCV-infected patients frequently experience renal failure, particularly after liver transplantation.

Purpose of the Study:

  • To characterize the renal histologic findings in patients with HCV-induced cirrhosis.
  • To correlate these findings with clinical features and renal function before liver transplantation.

Main Methods:

  • A case series design was employed at a single US liver transplant center.
  • Kidney biopsies were performed during liver engraftment in 30 patients with HCV cirrhosis.
  • Clinical and laboratory data on renal function were collected within six months pre-transplant.

Main Results:

  • Immune-complex glomerulonephritis was diagnosed in 25 of 30 patients (83%).
  • Specific types included membranoproliferative glomerulonephritis (n=12), IgA nephropathy (n=7), and mesangial glomerulonephritis (n=6).
  • Renal abnormalities were often subtle, with 10 patients having normal serum creatinine and urinalysis, and 5 others showing only elevated creatinine.

Conclusions:

  • Immune-complex glomerulonephritis is a frequent, often subclinical, finding in HCV-related cirrhosis.
  • This condition may be an underrecognized contributor to renal failure post-liver transplantation.
  • Further research is needed to understand post-transplantation outcomes.
Abstract

Related Concept Videos

Kidney Transplant I: Introduction01:28

Kidney Transplant I: Introduction

A kidney transplant is a surgical approach that involves replacing a non-functioning kidney with a healthy one from a donor. This procedure is often a treatment option for end-stage renal disease (ESRD) patients. The method requires careful recipient selection, including evaluating various medical and psychosocial factors. These criteria vary between transplant centers but generally include assessments of the patient's overall health, adherence to medical recommendations, and lifestyle...
849
Kidney Transplant II: Surgical Procedure01:26

Kidney Transplant II: Surgical Procedure

Preoperative ManagementThe primary goals of preoperative management in kidney transplantation are to optimize the patient’s metabolic state and prepare them for surgery through diet adjustments, necessary dialysis, and tailored medical treatment. This phase also involves comprehensive infection screening and patient education about the surgical procedure and postoperative care to improve outcomes and adherence.Medical ManagementA comprehensive evaluation is required for both the living...
955
Kidney Transplant III: Nursing Management01:16

Kidney Transplant III: Nursing Management

Postoperative Nursing Management for Kidney Transplant PatientsPostoperative nursing management care includes monitoring the surgical site, encouraging early movement, and promoting lung health through breathing exercises. Nurses also administer prescribed medications like H2-blockers, such as famotidine, or proton pump inhibitors, like omeprazole, to help prevent gastrointestinal ulcers and bleeding. Fungal infections in the mouth and bladder can result from immunosuppressive and antibiotic...
647
Hepatitis01:25

Hepatitis

Hepatitis is an inflammatory condition of the liver most commonly caused by hepatotropic viruses (A–E), though non-infectious causes such as alcohol and drugs also exist.Hepatitis AHepatitis A virus (HAV) is a non-enveloped RNA virus of the Picornaviridae family. It is primarily transmitted via the fecal-oral route, typically through ingestion of contaminated food or water. After ingestion, HAV enters the bloodstream through the oropharynx or intestinal epithelium and reaches the liver.
99
Cirrhosis I: Introduction01:23

Cirrhosis I: Introduction

Cirrhosis is a chronic, irreversible liver disease characterized by the widespread replacement of healthy liver tissue with fibrotic scar tissue and the formation of regenerative nodules.Etiology of cirrhosisCirrhosis results from sustained liver injury that triggers progressive fibrosis and structural remodeling. The underlying causes are diverse, encompassing common and less frequent clinical conditions. Regardless of the origin, all causes lead to chronic inflammation, hepatocyte loss, and...
30
Cirrhosis II: Pathophysiology01:24

Cirrhosis II: Pathophysiology

Cirrhosis is a progressive chronic liver injury caused by prolonged inflammation, excessive fibrotic remodeling, and impaired regeneration. Over time, repeated hepatic insults disrupt the liver’s architecture and function, leading to reduced blood flow, impaired bile drainage, and diminished metabolic capacity.Pathophysiology of cirrhosisCirrhosis arises from three main responses to chronic liver damage: inflammation, immune activation, and hepatocyte death. These processes lead to...
49